A Comparison of the Original Chronic Respiratory Questionnaire with a Standardized Version

Chest

Volumn 124, Issue 4, 2003, Pages 1421-1429

  Schünemann, Holger J ^a,d   Griffith, Lauren ^b   Jaeschke, Roman ^b   Goldstein, Roger ^c   Stubbing, David ^b   Austin, Peggy ^b   Guyatt, Gordon H ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

COPD; Health related quality of life; Respiratory questionnaires; Responsiveness

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INSTRUMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY AIRFLOW; SCORING SYSTEM; STANDARD; STATISTICAL SIGNIFICANCE;

EID: 10744226727     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.4.1421     Document Type: Article

References (22)

1. van den Boom G, Rutten-van Molken MP, Molema J, et al. The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease: results of the DIMCA program. Am J Respir Crit Care Med 2001; 164:2057-2066
2. Cook D, Guyatt G, Wong E, et al. Regular versus as-needed short-acting inhaled β-agonist therapy for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 85-90
3. Green RH, Singh SJ, Williams J, et al. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2001; 56:143-145
4. Brightling CE, Monterio W, Green RH, et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001; 95:999-1002
5. Neder JA, Sword D, Ward SA, et al. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57:333-337
6. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42:773-778
7. Tu SP, McDonell MB, Spertus JA, et al. A new self-administered questionnaire to monitor health-related quality of life in patients with COPD: Ambulatory Care Quality Improvement Project (ACQUIP) Investigators. Chest 1997; 112:614-622
8. Wijkstra PJ, TenVergert EM, Van Altena R, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994; 49:465-467
9. Morgan MD. Experience of using the CRQ (Chronic Respiratory Questionnaire). Respir Med 1991; 85:23-24
10. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995; 107:187S-193S
11. Guyatt GH, Townsend M, Keller J, et al. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 1991; 85:17-21
12. Schünemann HJ, Guyatt GH, Griffith L, et al. A randomized controlled trial to evaluate the effect of informing patients about their pretreatment responses to two respiratory questionnaires. Chest 2002; 122:1701-1708
13. Schünemann H, Griffith L, Stubbing D, et al. A clinical trial to evaluate the responsiveness and validity of two direct health state preference instruments administered with and without hypothetical marker states in chronic respiratory disease. Med Decis Making 2003; 23:140-149
14. Goldstein RS, Gort EH, Stubbing D, et al. Randomised controlled trial of respiratory rehabilitation. Lancet 1994; 344:1394-1397
15. Jaeschke R, Guyatt GH, Willan A, et al. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax 1994; 49:479-484
16. Ware JE, Kosinski MA. SF-36 health survey manual and interpretation guide. Boston, MA: New England Medical Center, 1993
17. Bennet KJ, Torrance G. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven, 1996; 253-265
18. Torrance G, Furlong W, Feeny D, et al. Multi-attribute preference functions: health utilities index. Pharmacoeconomics 1995; 6:503-520
19. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19:787-805
20. Mahler D, Weinberg DH, Wells CK, et al. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85:751-758
21. Guyatt G, King DR, Feeny DH, et al. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999; 52:187-192
22. Moran LA, Guyatt GH, Norman GR. Establishing the minimal number of items for a responsive, valid, health-related quality of life instrument. J Clin Epidemiol 2001; 54:571-579